BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+23.73%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$8.79B
AUM Growth
+$8.79B
(-49%)
Cap. Flow
-$9.78B
Cap. Flow
% of AUM
-111.33%
Top 10 Holdings %
Top 10 Hldgs %
80.97%
Holding
105
New
4
Increased
25
Reduced
11
Closed
21
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$159M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$98.3M |
| 3 |
Revolution Medicines
RVMD
|
$70.5M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$67.8M |
| 5 |
Replimune Group
REPL
|
$41.9M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.45B |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$337M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$198M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$69.4M |
| 5 |
Roivant Sciences
ROIV
|
$48.1M |
Sector Composition
| 1 | Healthcare | 98.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WHWK
76
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $508K | 0.01% |
251,727
-738,201
| -75% | -$1.49M |
|
77
Protara Therapeutics
TARA
$125M
| $374K | ﹤0.01% |
199,671
| – | – |
|
78
Cabaletta Bio
CABA
$144M
| $303K | ﹤0.01% |
13,331
-1,580,669
| -99% | -$35.9M |
|
79
Foghorn Therapeutics
FHTX
$298M
| $290K | ﹤0.01% |
45,027
| – | – |
|
|
BCEL
80
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $287K | ﹤0.01% |
2,177,499
-1,355,261
| -38% | -$179K |
|
81
Tyra Biosciences
TYRA
$657M
| $147K | ﹤0.01% |
+10,607
| New | +$147K |
|
82
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $16.2K | ﹤0.01% |
833,333
| – | – |
|
|
AFMD
83
DELISTED
Affimed
AFMD
| – | – |
-444,864
| Closed | -$2.13M |
|
84
Alector
ALEC
$282M
| – | – |
-964,851
| Closed | -$6.25M |
|
85
AnaptysBio
ANAB
$630M
| – | – |
-106,197
| Closed | -$1.91M |
|
86
Arvinas
ARVN
$580M
| – | – |
-413,481
| Closed | -$8.12M |
|
|
BLUE
87
DELISTED
bluebird bio
BLUE
| – | – |
-124,986
| Closed | -$7.6M |
|
|
88
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-3,810,248
| Closed | -$337M |
|
89
Cogent Biosciences
COGT
$1.83B
| – | – |
-1,292,966
| Closed | -$12.6M |
|
90
Geron
GERN
$893M
| – | – |
-3,061,224
| Closed | -$6.49M |
|
91
Heron Therapeutics
HRTX
$204M
| – | – |
-8,131,678
| Closed | -$8.38M |
|
|
ITOS
92
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-150,346
| Closed | -$1.65M |
|
93
Natera
NTRA
$23B
| – | – |
-100,000
| Closed | -$4.43M |
|
94
Pacific Biosciences
PACB
$378M
| – | – |
-1,127,782
| Closed | -$9.42M |
|
95
Avidity Biosciences
RNA
$6.12B
| – | – |
-166,347
| Closed | -$1.06M |
|
96
Summit Therapeutics
SMMT
$17.5B
| – | – |
-3,140,473
| Closed | -$5.87M |
|
|
SWTX
97
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-2,999,846
| Closed | -$69.4M |
|
98
Instil Bio
TIL
$196M
| – | – |
-235,220
| Closed | -$2.01M |
|
99
Vor Biopharma
VOR
$253M
| – | – |
-633,848
| Closed | -$1.34M |
|
|
MORF
100
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-215,800
| Closed | -$4.94M |
|